ReVision Optics said today that it raised $32 million in an equity round to back the commercialization of its Raindrop near-vision inlay. Existing backers Canaan Partners, Domain Associates, InterWest Partners and ProQuest Investments also participated in the round, Lake Forest, Calif.-based ReVision said. The Raindrop inlay, which won pre-market approval from the FDA in June, is a […]
Funding Roundup
Intuity Medical raises $40m for Pogo glucose meter
Intuity Medical said today that it raised $40 million in a Series C round for its Pogo 1-step blood glucose meter. Sunnyvale, Calif.-based Intuity said the round was led by PTV Healthcare Capital and included affiliates of Luther King Capital Management, both new investors, and existing backers Accuitive Medical Ventures, Investor Growth Capital, U.S. Venture Partners, Venrock […]
Siemens plans IPO for healthcare business
Reuters — Siemens (NYSE:SI) said today that it’s planning a public listing for its $15 billion healthcare business, lifting its shares to a 16-year high as investors hoped for an injection of capital that would lift its valuation while funding future investments. Healthcare is the most profitable business of the trains-to-turbines group but will need large investments […]
Cohero raises $9m Series A for smart inhalers
Cohero Health said today that it closed a $9 million Series A round for its BreatheSmart patient monitoring platform, which can track medication adherence and measure lung functioning. The funds are also earmarked for commercial development efforts and expanding Cohero’s clinical trial program. The round was led by Three Leaf Ventures with participation by Zaffre Investments and BioAdvance, Cohero […]
Titan Medical adds $900k to $8m overnight offering
Titan Medical (TSE:TMD) said today that it brought in another $909,000 after the underwriters of an overnight offering picked up their over-allotment option. Toronto-based Titan said it sold some 2 million shares at about 44.8¢ (C60¢) apiece, adding $909,000 (C$1.2 million) to the $7.7 million (C$10.25 million) it raised in the initial offering last month. Titan had hoped […]
Jivana Biotechnology raises $1m for targeted cancer therapy
Jivana Biotechnology raised $1 million for its preclinical work using targeted RNA-based therapies to treat a variety of cancers, according to a regulatory filing the Oak Park, Ill.-based company submitted this week. The minimum investment from an outside investor was $50,000, the company reported, and it used an estimated $125,000 for payments to its executive […]
Wound care giant Convatec prices $1.8B IPO
Danish wound care and colostomy supply maker ConvaTec today priced an initial public offering that grossed nearly $1.8 billion on the London Stock Exchange. ConvaTec, which is owned by private equity firms Avista Capital Partners and Nordic Capital, said it put up 33.8% of its shares in the flotation, which could rise to 38.9% if the underwriters fully exercise an over-allotment […]
CollPlant files for $25 million IPO
Regenerative medicine company CollPlant today released information on its planned initial public offering, looking to bring in $25 million. CollPlant produces wound care and regenerative devices based on plant-derived collagen. Their products include the Vergenix FG flowable gel intended to treat chronic and acute wounds. The wound-filling gel utilizes Israel-based CollPlant’s proprietary tobacco plant-based technology, […]
NovioSense closes 4th financing round for tear glucose sensor
NovioSense said today that it closed a 4th financing round to support the upcoming clinical validation phase of its smartphone-based tear glucose sensor device. The round included existing investors such as Health Innovations, Fraunhofer Ventures and NovioTech, as well as 2 new U.S.-based investors, NovioSense said. The flexible, miniature tear glucose sensor rests on the lower eyelid […]
Bigfoot Biomedical raises $36m Series A for Smartloop artificial pancreas program
Bigfoot Biomedical said yesterday that it raised $35.5 million in a Series A round for the artificial pancreas technology it’s developing to treat Type I diabetes. The round, led by Quadrant Capital Advisors, included backing from Cormorant Asset Management, Senvest Capital, and Visionnaire Ventures. Bigfoot said it plans to use the proceeds to fund the final development of […]
iRhythm prices IPO above the range, raises $107m
iRhythm Technologies yesterday increased the scale of its initial public offering, pricing the flotation above its prior range at $17 per share and increasing the number of shares on offer. Earlier this month iRhythm said it planned to float 5.35 million shares priced between $13 and $15 apiece. Yesterday the San Francisco-based company added nearly 1.1 million shares, for a […]